Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma
|
168 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.020 | 1.000 | 2 | 2014 | 2016 | ||||||
Adult Oligodendroglioma
|
19 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Benign Neoplasm
|
7 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||||
Carcinogenesis
|
355 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Carcinoma, Signet Ring Cell
|
6 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinoma, Spindle-Cell
|
5 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Childhood Embryonal Rhabdomyosarcoma
|
7 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Childhood Oligodendroglioma
|
19 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Embryonal Rhabdomyosarcoma
|
8 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Esophageal carcinoma
|
272 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Esophageal Neoplasms
|
270 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Immunologic Deficiency Syndromes
|
31 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.020 | 1.000 | 2 | 2005 | 2010 | ||||||
Malignant neoplasm of esophagus
|
214 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Malignant neoplasm of pancreas
|
277 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Malignant tumor of colon
|
688 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2006 | 2006 | ||||||
Neoplasms
|
1644 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.060 | 0.833 | 6 | 2010 | 2019 | ||||||
oligodendroglioma
|
21 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||
Pancreatic carcinoma
|
322 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
Rhabdomyosarcoma
|
20 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Stomach Neoplasms
|
55 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Well Differentiated Oligodendroglioma
|
22 | 0.716 | 0.120 | 17 | 7675097 | missense variant | A/C;G | snv | 0.010 | 1.000 | 1 | 2011 | 2011 |